In a time of increasingly bespoke healthcare, Elizabeth Philp has established herself as a significant force of innovation, notably in the tech-driven field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the forefront of a drive to make bespoke medications more available, questioning the conventional one